KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) Research & Development (2016 - 2025)

Historic Research & Development for Illumina (ILMN) over the last 17 years, with Q4 2025 value amounting to $239.0 million.

  • Illumina's Research & Development fell 664.06% to $239.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $967.0 million, marking a year-over-year decrease of 1756.18%. This contributed to the annual value of $967.0 million for FY2025, which is 1727.97% down from last year.
  • Per Illumina's latest filing, its Research & Development stood at $239.0 million for Q4 2025, which was down 664.06% from $229.0 million recorded in Q3 2025.
  • Illumina's 5-year Research & Development high stood at $486.0 million for Q1 2023, and its period low was $197.0 million during Q2 2021.
  • For the 5-year period, Illumina's Research & Development averaged around $299.5 million, with its median value being $319.0 million (2022).
  • Its Research & Development has fluctuated over the past 5 years, first soared by 15348.84% in 2021, then crashed by 2983.54% in 2023.
  • Quarter analysis of 5 years shows Illumina's Research & Development stood at $436.0 million in 2021, then decreased by 25.46% to $325.0 million in 2022, then increased by 4.92% to $341.0 million in 2023, then fell by 24.93% to $256.0 million in 2024, then fell by 6.64% to $239.0 million in 2025.
  • Its Research & Development stands at $239.0 million for Q4 2025, versus $229.0 million for Q3 2025 and $247.0 million for Q2 2025.